Evidence map›Paper›PMID 31832406›Full record

ArticleWorld journal of clinical cases2019

Takashi Anayama, Mai Taguchi, Takehiro Tatenuma, Hironobu Okada, Ryohei Miyazaki, Kentaro Hirohashi, Motohiko Kume, Keisuke Matsusaki, Kazumasa Orihashi

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical cases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Takashi AnayamaDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan. anayamat@kochi-u.ac.jp.
Mai TaguchiDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.
Takehiro TatenumaDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.
Hironobu OkadaDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.
Ryohei MiyazakiDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.
Kentaro HirohashiDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.
Motohiko KumeDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.
Keisuke MatsusakiJapanese CART Study Group, Kaname Second Clinic, Kanamecho Hospital, Tokyo 171-0043, Japan.
Kazumasa OrihashiDepartment of Surgery II, Kochi Medical School, Kochi University, Kochi 783-8505, Japan.
Kōchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe report the first case, to the best of our knowledge, of massive ascites due to recurrent malignant pleural mesothelioma that was controlled using KM-cell-free and concentrated ascites reinfusion therapy (KM-CART). The tumor cells derived CASE SUMMARY: A 56-year-old man presented with recurrent malignant mesothelioma with massive ascites; more than 4000 mL of ascitic fluid was removed, filtered, and concentrated using KM-CART, and the cell-free ascitic fluid was reinfused into the patient to improve quality of life. Cancer cells isolated secondarily in an

conclusionThe combination of KM-CART and CD-DST may be a promising treatment option for malignant ascites associated with malignant mesothelioma.

Indexed as

AscitesCancerCase reportMalignantMesotheliomaPalliative therapyPemetrexed

Identifiers

PMID31832406
PMCPMC6906570
OpenAlexW2994153924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.